Skip to content
Sign up today for access to the latest pediatric solutions!
Sign up today for access to the latest pediatric solutions!

IP License - Antepartum Administration of Lactoferrin for Potential Preventative Intervention Against Neonatal Sepsis

IP Licensing
Availability: Available On Demand

For informational purposes only. Please contact seller directly for more details.

Share This:

Prenatal maternal vaginal administration of lactoferrin (LF) significantly decreases vaginal bacterial loads of a clinically significant neonatal invasive E. coli isolate. Placental bacterial loads, and burden of infection in the offspring were also significantly decreased. Prenatal lactoferrin is a potential preventative intervention against neonatal sepsis. Patent Pending

Shipping Information

Digital delivery/downloads will typically be delivered within 2 business days.

Physical products typically take 5-8 business days. Please contact the seller directly with any questions about your order.

You will receive an order confirmation email from PedsMrkt followed by a shipping email when your order ships.

Returns

Please contact the seller directly for their return policy and to
handle returns. Customer will be responsible for return shipping fees.